Investors in Novartis can expect a huge dividend payment. Based on the recent analysts' consensus the stock now has one of the highest dividend returns of the Swiss market. Per share the analysts expect a dividend of 2,95 CHF per share. The dividend yield is then 3,75 percent. The average dividend yield of the pharmaceutical companies equals a limited 0,5 percent.
Tomorrow the Swiss Novartis will report its past quarter's results. For this year Novartis 's revenue will be around 52,1 billion CHF. This is according to the average of the analysts' estimates. This is slightly more than 2017's revenue of 50,14 billion CHF.
The analysts expect for 2018 a net profit of 11,76 billion CHF. According to most of the analysts the company will have a profit per share for this book year of 5,17 CHF. The PE-ratio therefore is 15,21.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.